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Abstract
Background: Substance use is a potentially modifiable risk factor for suicidal behaviour. Little is known about the
epidemiology of substance use among self-harm patients in South Africa. This study set out to collect epidemiological
data about the prevalence, correlates, and patterns of medical service utilisation among self-harm patients who used
substances at the time of self-injury.
Methods: Data from 238 consecutive self-harm patients treated at an urban hospital in South Africa were analysed
using bivariate and multivariate statistics.
Results: Approximately 20% of patients reported substance use at the time of self-harm. When compared to other self-
harm patients, higher rates of patients who had used substances: had depressed levels of consciousness on admission;
utilised more medical resources and required longer hospital admissions; cited relationship difficulties and financial
concerns as reasons for their self-harm; reported a previous episode of self-harm; and intended to die as a
result of their injuries. Although the observed differences were not statistically significant (p > 0.05), the proportional
differences were congruent with international literature.
Conclusion: Acute use of substances among self-harm patients warrants more focused research and clinical attention
particularly in the context of reducing utilisation of scarce medical resources.
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Background
Substance use is a recognised risk factor for self-harm
(i.e., intentional, non-habitual self-injury with or without
intent to die) and completed suicide [1]. Extensive litera-
ture documents the relationship between alcohol use
and self-harm [2, 3]. A comparatively smaller body of lit-
erature describes associations between self-harm and the
use of cannabis [4], heroin [5], methamphetamines [6]
and cocaine [7]. Literature in this area comes predomin-
antly from high-income Western countries. Research
from low and middle-income countries is relatively scant
despite the fact that 75.5% of all suicides occur in these
countries [8]. To date no studies in South Africa (SA)
document the prevalence and correlates of substance
use among persons who engage in self-harm, although
there is some evidence to suggest that completed sui-
cides in the country are associated with substance use
[9]. This study documents the prevalence and corre-
lates of acute use of substances (AUS) (i.e., substance
use during or shortly before engaging in self-injurious
behaviour) [10] among patients treated at an urban
hospital in SA.* Correspondence: elsie@sun.ac.za
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Acute use of substances and self-harm in high-income
countries
An abundance of literature from high-income countries
report on the association between AUS and self-harm.
The findings from cross-sectional studies show that AUS
is associated with self-harm among males [11], and
younger adults [1]. Moreover, evidence suggests that
AUS (in particular the quantity of substances used and
the time between substance use and self-harm) is associ-
ated with methods of self-harm that entail damage to
body tissues such as hanging, cutting, burning, and gun
shots [12]. High levels of substance use during social
events are associated with self-harm, independent of the
level of suicidal intent, as a result of disinhibition, in-
creased impulsivity, impaired judgement, increased
feelings of depression or hopelessness, and the urge to
escape a situation or to change the behaviour of some-
one else [13, 14]. In cases with higher levels of intent to
die and premeditation, AUS may facilitate self-harm by
easing the distress of engaging in self-harm [15].
Substance use by self-harm patients may influence
their medical management, the treatment they receive
and the clinical decisions of medical staff. Ries and col-
leagues reported that self-harm patients who had used
substances at the time of injury were discharged sooner
than patients whose behaviour was not perceived to be
related to substance use [16]. Clinicians believe that
AUS related self-harm is linked to lower levels of pre-
meditation (i.e., is more impulsive) and lower levels of
suicidal intent [15]. This belief together with aggressive
or uncontrolled behaviour upon arrival at the emergency
department, seems to lead to self-harm patients who
had been using substances receiving less intensive
medical care and being discharged sooner than pa-
tients who did not have a substance-related risk for
suicidal behaviour [17].
Substance use and suicidal behaviour in South Africa
Alcohol is the most common substance used in SA [18].
Widespread unrecorded alcohol production (e.g., home-
brewing of beer) and illegal selling of alcohol, make it
difficult to accurately estimate alcohol consumption in
SA [19]. Yet, available prevalence rates of lifetime alco-
hol use in the Western Cape range from 39% to 64%,
while rates of risky drinking range from 9% to 34% [20].
Data on illicit drug use in SA is limited. Cannabis is the
most common drug used (approximately 2% of the
population), followed by cocaine (0.3%), sedatives (0.3%),
amphetamines (0.2%), inhalants, hallucinogens, and opi-
ates (0.1% each) [21]. However, these rates are thought
to be underestimated with a report from the Inter-
national Narcotics Board suggesting that up to 15% of
the country’s population regularly use some form of
illicit drug [22].
Approximately 11% of non-natural deaths in SA are
suicide-related [23] and an estimated 40% of suspected
deaths by suicide test positive for assays of blood alcohol
[9]. Nationally representative data from the South
African Stress and Health study suggest that substance
use disorder increased the risk for suicide attempts (OR =
4.1), more than any other common mental disorder [24].
Better understanding the relationship between AUS
and self-harm in SA may help identify strategies to re-
duce the morbidity and mortality associated with self-
harm and to lessen the burden placed on the health care
system; a system that is already under-resourced and
overburdened [25, 26]. The aim of this study was to col-
lect epidemiological data about the prevalence and
correlates of AUS among self-harm patients seeking
treatment in an urban hospital in the Western Cape
Province of SA (hereafter referred to as the hospital).
A secondary aim was to describe the pattern of
medical service utilisation among this group of self-
harm patients.
Methods
Data collection procedures
This study consisted of a point prevalence sample from
a small population by collecting data from all self-harm
patients who presented for treatment at the hospital be-
tween 16 June 2014 and 29 March 2015. During this
time there were 270 consecutive presentations of self-
harm, of which 238 were eligible for inclusion. Cases
were excluded if: the files were missing or there was not
sufficient information available in the patient file (17 pa-
tients); the patient had already been included in the
sample on a prior presentation to the hospital during
the period of data collection (9 patients); patients left
the hospital before data was captured (1 patient); or
patients died as a result of their injuries (5 patients).
Sample size calculations were based on 15 patients
per predictor variable in each model of logistic re-
gression [27].
Definition of self-harm
In this study self-harm is defined as intentional self-
injury or self-poisoning with non-fatal outcome, regard-
less of the degree of intent to die, which is deliberate
and is non-habitual [1, 8, 28]. The term self-harm, as we
have defined it, is synonymous with the term ‘deliberate
self-harm’ and includes suicide attempts but does not in-
clude habitual or repetitive self-injury. We did not con-
fine our study to suicide attempts because we could not
reliably determine intent to die in order to differentiate
suicide attempts from other forms of deliberate self-
harm. This inclusion of cases of self-harm regardless of
the level of intent is consistent with the approach
adopted in other studies [29] and with the WHO’s
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inclusion of self-harm as a component of non-fatal sui-
cidal behaviour [8]. Within our definition of self-harm,
substance use would not be considered a form of self-
harm since this behaviour is both habitual and the use
of substances is not primarily motivated by a conscious
desire to inflict bodily harm.
Measures
The following data was collected:
Demographic information
Patient’s age, gender, ethnicity, home language, relation-
ship status, number of dependents, level of education,
and employment status. It is worth noting that the hos-
pital only treats patients 13 years and older. Socio-
economic status (SES) was also recorded as low to mod-
erate SES (ZAR0 to ZAR76 800) and high SES (ZAR76
801 to ZAR2 547,601) based on annual family income.
Substance use
Self-reports of substance use at the time of self-harm,
and type of substance(s) used. Rates of substance use
may be limited by underreporting when relying on self-
report measures. However, in SA self-report measures
for harmful alcohol use and drug-related problems
showed some agreement when compared to the use of
biomarkers to determine substance use [30]. Studies that
compare self-report measures with more objective mea-
sures of illicit use of other substances are scant.
Clinical features of self-harm
Method(s) of self-harm; medical intervention(s) received;
psychiatric assessment conducted; level of admission re-
quired (i.e., treated and discharged, or admitted to the
ICU, high care, medical / surgical ward, or emergency
psychiatric unit), and length of stay in the hospital.
Level of consciousness on admission
The Glasgow Coma Scale (GCS) was used to measure
the level of responsiveness to stimuli (i.e., level of con-
sciousness) on arrival at the hospital. This study consid-
ered a score of 13 to 15 to indicate no or minimal
depression in level of consciousness (LOC), a score of 9
to 12 indicated moderately depressed LOC, and a score
of 8 or less indicated significantly depressed LOC.
Level of suicidal intent
The 12-item Pierce Suicidal Intent Scale (PSIS) was used
to measure suicidal intent among patients [31]. The PSIS
scores range from zero to 25, where scores between zero
and three indicates low suicidal intent, scores between
four and 11 indicates moderate suicidal intent, and
scores higher than 11 indicates severe suicidal intent. In
this study, only three AUS patients reported low suicidal
intent. The small number of patients makes meaningful
analysis difficult. Therefore, two categories were created
for the analysis consisting of low to moderate suicidal
intent (i.e., scores between zero and 11) and high sui-
cidal intent (i.e., scores higher than 11).
Details of self-harm
Patient’s self-report of the stated intention for self-harm,
reasons for engaging in the behaviour, history of a previ-
ous episode of self-harm, and whether the incident was
impulsive (as opposed to planned).
The data was collected from patient records. The re-
cording of this data is part of the routine clerking of all
self-harm patients in the hospital. Quality checks for
possible errors and missing data were done throughout
data collection.
Statistical analyses
Data were analysed using SPSS v.18. Following descrip-
tive analyses, bivariate analyses of the association
between AUS and self-harm were performed using chi-
square statistics or Fisher’s exact test for categorical vari-
ables. Odds ratios (OR) and 95% confidence intervals
(CI) were calculated for variables with significant
p-values. The Mann-Whitney test was used for between-
group analyses of continuous variables with nonnormal
distributions. Logistic regression analysis was used to ex-
plore the relationship between AUS and gender, SES,
having dependents, suicidal intent, history of previous
self-harm, LOC on admission, medical intervention re-
quired, level of suicidal intent, whether a psychiatric as-
sessment was received, hospital admission required, and
whether the self-harm was impulsive as opposed to
planned. Statistical significance was set at p < 0.05.
Ethical approval
Ethical approval for this study was granted by the Health
Sciences Research Ethics Committee: at Stellenbosch
University (reference number: N13/05/074) and University
of Cape Town (reference number: 645/2013). Written
permission was granted by the hospital before patient
records were accessed. Information collected from pa-
tient records were saved on a password protected
computer where each patient was assigned a unique
number to protect patient confidentiality.
Results
Demographic characteristics of sample
The sample consisted of 238 self-harm patients, of which
20.2% reported substance use at the time of self-injury
(i.e., AUS). The demographic characteristics of the sub-
group of AUS patients and other self-harm patients with
no AUS is shown in Table 1. The mean age of AUS pa-
tients was 32.9 (SD = 11.8) years, while the mean age of
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other self-harm patients was 31.2 (SD = 14.3) years.
The sub-group of AUS patients were predominantly
male (52.1%), black (37.5%), not in a relationship
(85.4%), unemployed (72.9%), and were of low- to
moderate SES (43.8%).
AUS self-harm patients were approximately 2.6 times
more likely not to have dependents [x2 = 5.95 (df = 1),
p = 0.015, OR = 2.59, 95% CI 1.122–6.119], when com-
pared to those who had not used any substances at
the time of their injuries. In the logistic regression
analysis, demographic characteristics (i.e., gender, SES,
and having dependents) did not predict AUS when
controlling for the other variables in the model (see
Additional file 1: Table S1).
Range of substances used
The range of substances used by self-harm patients is
provided in Table 2. Alcohol (73%) was the most com-
monly used substance, while methamphetamine (10.4%),
cannabis (6.25%), cocaine (6.25%), and heroin (4.17%)
use was also reported. Only one patient reported using
Table 1 Description and comparison of sample demographic characteristics, by acute use of substances
Variable Yes an = 48 (%) No bn = 190 (%) χ2 df p -value OR (CI)
Gender
Male 25 (52.1) 71 (37.4) 3.45 1 0.063
Female 23 (47.9) 119 (62.6)
Mean (SD) Age (years) 32.9 (11.8) 31.2 (14.3)
cRace 7.93 4 0.094
Black 18 (37.5) 64 (33.7)
Asian/Moslem 1 (2.1) 7 (3.7)
dColoured 15 (31.3) 88 (46.3)
White 12 (25.0) 21 (11.1)
Not known 2 (4.2) 10 (5.3)
Relationship status – – –
Married/In a relationship 7 (14.6) 39 (20.5)
Not in a relationship 41 (85.4) 150 (78.9)
Not Known 0 1 (0.5)
Have dependents 5.95 1 0.015 2.59 (1.12–6.12)
No dependents/pregnant 39 (81.3) 119 (62.6)
Dependents 9 (18.8) 71 (37.4)
eCompleted level of education 5.92 2 0.052
Primary school 24 (50.0) 76 (40.0)
Secondary school 13 (27.1) 87 (45.8)
Tertiary school (Undergraduate or postgraduate) 11 (22.9) 27 (14.2)
fEmployment status – – –
Employed 13 (27.1) 44 (23.2)
Unemployed (unemployed, scholar, student) 35 (72.9) 141 (74.2)
Not known 0 5 (2.6)
gSES 5.23 2 0.073
Low to moderate SES (ZAR0 to ZAR76 800) 21 (43.8) 110 (57.9)
High SES (ZAR76 801 to ZAR2 547,601) 19 (39.6) 66 (34.7)
Not known 8 (16.7) 14 (7.4)
Total sample = 238. OR = Odds Ratio; CI = confidence intervals. Chi-square statistics were calculated for categorical variables: gender, race, having dependents or
no dependents, completed level of education, and socio-economic status (SES). Mann-Whitney U test was used for between-group analyses of continuous variables
with nonnormal distribution: Mean age (years)
an = 48; bn = 190; cRace = the term race may be offensive in some countries, however this is an official term used in South Africa. dColoured = the term coloured
may be offensive in some countries, however this is an official term used in South Africa. ePrimary school = 1st grade to 7th grade in the United States; Secondary
school = 8th grade to 12th grade/Senior in the United States; Tertiary school = any Diploma or University degree after completing Grade 12. fEmployment status =
6 participants who indicated that they were retired were included in the employed category as they qualify to receive old age pension from the state worth
ZAR1420 per month. gZAR15.72 = 1 US dollar
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Table 2 Description and comparison of clinical features by acute use of substances
Variable Yes an = 48 (%) No bn = 190 (%) χ2 df p-value
cAcute substance used
Alcohol 35 (72.9)
Cannabis 3 (6.25)
MDMA (Ecstasy) 1 (2.08)
Methaqualone (Mandrax) 2 (4.17)
Cocaine 3 (6.25)
Methamphetamine (Tik) 5 (10.4)
Heroin 2 (4.17)
Opiates 1 (2.08)
Multiple substance use
Yes 9 (18.8)
No 39 (81.3)
Method of self-harm
Self-poison 37 (77.1) 154 (81.1) 0.381 1 0.537
Prescription medication 27 (56.3) 118 (62.1) 0.552 1 0.458
Non-prescription medication 17 (35.4) 57 (30.0) 0.525 1 0.469
Ingestion or inhalation of poison 3 (6.25) 22 (11.6) 1.16 1 0.429
Damage body tissue 8 (16.7) 26 (13.7) 0.278 1 0.598
Laceration 4 (8.33) 18 (9.47) 0.040 1 0.769
Hanging 3 (6.25) 13 (6.84) 0.021 1 1.00
Asphyxiation 1 (2.08) 1 (0.53) 1.12 1 0.291
Immolation 1 (2.08) 0 – – –
Jumped off a height 2 (4.17) 1 (0.53) 0.332 1 0.564
Jumped in front of a train 1 (2.08) 2 (1.05) 0.327 1 0.493
Mixed method (i.e. self-poison and damage to body tissue) 3 (6.3) 8 (4.2) 0.290 1 0.703
Not known 0 2 (1.1) – – –
dGlasgow Coma Scale (Level Of Consciousness) 0.099 2 0.095
Minimal depression in LOC 40 (83.3) 161 (84.7)
Moderately depressed LOC 3 (6.3) 12 (6.3)
Significantly depressed LOC 5 (10.4) 17 (8.9)
Received medical intervention 0.269 1 0.604
Yes 32 (66.7) 119 (62.6)
No 16 (33.3) 71 (37.4)
ePierce Suicide Intent Scale (PSIS) 0.079 2 0.961
Low to moderate suicide intent 17 (35.4) 69 (36.3)
High suicide intent 8 (16.7) 34 (17.9)
Not known 23 (47.9) 87 (45.8)
Received a psychiatric assessment 0.031 1 0.859
Yes 34 (70.8) 137 (72.1)
No 14 (29.2) 53 (27.9)
Total sample = 238. Chi-square statistics were calculated for categorical variables: level of consciousness, medical intervention received, level of suicidal intent, and
whether or not a psychiatric assessment was received
an = 48; bn = 190; cDescription of type of, and single or multiple acute substance use; dNo or minimal depression in level of consciousness = a score of 13 to 15 on
the Glasgow Coma scale; moderately depressed level of consciousness = a score of 9 to 12 on the Glasgow Coma scale; significantly depressed level of consciousness =
a score of 8 or less on the Glasgow Coma scale. eLow to moderate suicide intent = a PSIS of 11 or lower; high suicide intent = PSIS score of 12 or more
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opioids. Multiple substance use at the time of the self-
injury was reported by 19% of the sample.
Methods of self-harm
The methods of self-harm are provided in Table 2. Self-
poisoning was the most common method of self-harm
among AUS patients (77.1%). Among patients who re-
ported self-poisoning, prescription medication was the
most common method used among AUS patients
(56.3%). There was no statistically significant association
between status of AUS (i.e., AUS patients and other self-
harm patients) and the methods of self-harm employed.
That is, AUS patients and other self-harm patients
equally reported the use of different methods of self-
harm (Table 2). In regression models, AUS did not pre-
dict whether patients used self-poisoning or damage to
bodily tissue (see Additional file 1: Table S1).
Level of consciousness on admission and medical
interventions required
A greater proportion of AUS, compared to other self-
harm patients, had moderate to severe depressed LOCs
on admission (16.7% vs. 15.2%), and required medical
intervention (66.7% vs. 62.6%). There was no statistically
significant association between status of AUS (i.e., AUS
patients or other self-harm patients) and LOC (Table 2).
In the regression analysis, AUS did not predict patients’
LOC, or whether a medical intervention was required
(see Additional file 1: Table S1).
Suicidal intent
A slightly smaller proportion of AUS, compared to other
self-harm patients, were assessed as having high levels of
suicidal intent (16.7% vs. 17.9%), and were referred for
psychiatric assessment (70.8% vs. 72.1%). There was no
statistically significant association between status of AUS
(i.e., AUS patients or other self-harm patients) and levels
of suicidal intent (Table 2). AUS did not predict suicidal
intent (see Additional file 1: Table S1).
Level of admission and length of hospital stay
Level of hospital admission required by self-harm pa-
tients and their length of stay in hospital, are provided
in Additional file 1: Table S2. Compared to other self-
harm patients, AUS self-harm patients spent more time
in short stay medical units [M = 3.44 days (SD = 2.06) vs.
M = 2.64 days (SD = 1.54)], long stay medical or surgical
wards [M = 25 days (SD = 34.1) vs. M = 15.1 days (SD =
22.4)], ICU or high care [M = 6.25 days (SD = 3.27) vs.
M = 4.62 days (SD = 3.69)], and in an emergency psychi-
atric unit [M = 6.80 days (SD = 5.89) vs. M = 6.46 days
(SD = 5.54)], although these differences were not statisti-
cally significant. AUS did not significantly predict whether
patients received a psychiatric assessment, whether patients
were treated in the emergency department and dis-
charged, or admitted to a long stay medical ward (see
Additional file 1: Table S1). Likewise, AUS did not
predict whether patients were admitted to the ICU or
a high care medical unit (see Additional file 1: Table S1).
Stated intention
The most common intentions reported by AUS patients
were to escape a situation (22.9%) and to communicate
something (e.g., distress) (27.1%) (Table 3). There was
no statistically significant association between status of
AUS (i.e., AUS patients or other self-harm patients) and
stated intension. .
Suicidal self-injury
A greater proportion of AUS, when compared to other
self-harm patients, stated that their intention was ‘to die’
(43.8% vs. 31.8%) There was no statistically significant as-
sociation between status of AUS (i.e., AUS patients or
other self-harm patients) and stated intension to die
(Table 3). AUS did not predict whether patients reported
that they intended to die (see Additional file 1: Table S1).
Stated reasons for self-harm
The most common reasons given for self-harm among
AUS patients were relationship (friendship, marital, or
romantic) issues (33.3%), financial concerns (27.1%), and
family conflict (22.9%) (Table 3). There was no statisti-
cally significant association between status of AUS (i.e.,
AUS patients or other self-harm patients) and stated rea-
son for self-harm (see Additional file 1: Table S1).
History of self-harm
Approximately half (45.8%) of AUS patients reported
one or more previous episodes of self-harm, while 35.3%
of other self-harm patients reported a previous episode
of self-harm. There was no statistically significant associ-
ation between status of AUS (i.e., AUS patients or other
self-harm patients) and history of self-harm (Table 3).
Impulsive self-harm
A smaller proportion of AUS patients (18.8%) reported
that their self-harm was impulsive compared to other
self-harm patients (24.7%). There was no statistically sig-
nificant association between status of AUS (i.e., AUS pa-
tients or other self-harm patients) and whether or not
the self-harm was impulsive (Table 3). In the logistic re-
gression, AUS did not predict whether the self-harm was
impulsive (see Additional file 1: Table S1).
Discussion
This study represents a small but important first step to-
wards better understanding the relationship between
AUS and self-harm in SA. In our sample, one in five
Breet et al. BMC Health Services Research  (2018) 18:157 Page 6 of 10
self-harm patients presenting for treatment at an urban
hospital reported that they had used substances at the
time of their self-harm.
Compared to other self-harm patients in the sample, a
greater proportion of patients who had used substances
at the time of their self-harm had a depressed level of
consciousness on admission, required a medical inter-
vention, were admitted to an ICU or high care unit, had
longer hospital stays than other self-harm patients, and
reported that they intended to die as a result of their in-
juries. These associations calculated using the Chi-
Square statistical test were not statistically significant
(p > 0.05), though the overall direction of the findings
were in keeping with studies from high-income countries
[12, 15, 32]. It is possible that given a larger sample and
more accurate measures of AUS, we would have found
the differences we observed to be statistically significant.
This increased level of medical service utilisation among
self-harm patients who had used substances at the time of
their injuries highlights the economic importance of ad-
dressing this health problem, particularly in the light of
scarce medical resources in SA [25, 26].
It is noteworthy that a higher proportion of self-harm
patients who had used substances report a history of
previous episodes of self-harm, compared to other self-
harm patients. This association was not found to be sig-
nificant (p > 0.05) when using the Chi-Square statistical
test, though the overall direction of the findings is
Table 3 Comparison of stated intention and reason, previous attempts, and impulsivity, by acute use of substances
Variable Yes an = 48 (%) No bn = 190 (%) χ2 df p-value OR (CI)
Stated Intention
To regulate the behaviour of someone else 6 (12.5) 49 (25.8) 3.81 1 0.051
To regulate emotional state 3 (6.3) 22 (11.6) 1.16 1 0.429
To escape a situation 11 (22.9) 37 (19.5) 0.282 1 0.595
To communicate something (e.g. distress) 13 (27.1) 69 (36.3) 1.45 1 0.229
Mistake 5 (10.4) 9 (4.74) 2.23 1 0.135
Chronic physical pain/illness 1 (2.1) 2 (1.05) 0.327 1 0.493
Not known 5 (10.4) 10 (5.26) 1.72 1 0.192
Suicidal self-injury (i.e., ‘to die’ as one of their reasons)
To die 21 (43.8) 60 (31.6) 2.53 1 0.126
Other 22 (45.8) 118 (62.1) 4.19 1 0.041
Not known 5 (10.4) 12 (6.32) 0.972 1 0.324
Stated Reason
Financial concerns 13 (27.1) 34 (17.9) 2.04 1 0.153
Friendship/Marital/romantic relationship issues 16 (33.3) 58 (30.5) 0.141 1 0.707
Family conflict 11 (22.9) 76 (40.0) 4.82 1 0.028 2.24 (1.02–5.00)
Social issues (i.e., isolation, friendship problems, legal issues) 2 (4.2) 10 (5.26) 31.3 1 0.000 24.7 (4.79–170.9)
Medical illness 6 (12.5) 12 (6.32) 2.10 1 0.148
Psychiatric illness 8 (16.7) 28 (14.7) 0.111 1 0.739
Bereavement 3 (6.3) 7 (3.68) 0.627 1 0.426
Academic concerns 2 (4.2) 13 (6.84) 0.464 1 0.742
Unplanned pregnancy 0 3 (1.58)
Not known 7 (14.6) 22 (11.6) 0.323 1 0.570
Previous attempt of self-harm 0.340
Previous attempt 22 (45.8) 67 (35.3)
No previous attempt 11 (22.9) 58 (30.5)
Not known 15 (31.3) 65 (34.2)
Impulsive act 0.382
Yes 9 (18.8) 47 (24.7)
No 39 (79.2) 143 (75.3)
Total sample = 238. Chi-square statistics were calculated for categorical variables: stated intention, stated reason, previous attempt of self-harm, and impulsive act
an = 48; bn = 190
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consistent with the international literature [33] and
highlights the need for targeted interventions to reduce
the risk of repetition among this population of patients.
The self-harm patients in this sample were all in contact
with the health care system as a result of the injuries they
had sustained. This contact with the health care system
represents a potential opportunity for targeted interven-
tions to address substance use problems, which seems to
be important given the finding that 20% of self-harm pa-
tients had used substances at the time of their self-harm.
Given that substance use is associated with risk of repeti-
tion of self-harm and eventual death by suicide [34], it
seems sensible to utilise this contact with the health care
system to address unhealthy patterns of substance use. It
may be beneficial to routinely screen for problem sub-
stance use among self-harm patients and to offer referrals
to appropriate substance use treatment centers or, where
appropriate, to deliver brief targeted interventions as part
of the management of self-harm at the hospital. This is
particularly important in SA where there are high rates of
substance use and problematic patterns of alcohol use
[18, 22]. The lack of accessible, affordable and effect-
ive treatments for substance use problems in SA [35]
is a significant barrier to suicide prevention.
There are some limitations to this study. As the data
was collected from one hospital setting it is not appropri-
ate to generalise the findings to other settings. Future re-
search should replicate this study by collecting data from
different hospitals across multiple settings. Some caution
is necessary when interpreting the findings since this study
recruited a consecutive sample, which is a type of non-
random purposive sampling and as such may result in se-
lection bias. This study did not take account of variables
such as the quantity of substances consumed, the context
in which substances were consumed (i.e., socially versus in
isolation) and the proximity of substance use to the inci-
dent of self-harm, which are potentially important vari-
ables. The data were collected from a retrospective review
of patient files that included self-reported information on
demographic information, substance use, and details of
self-harm that was collected during routine assessment of
self-harm patients. The nature of the self-report measures
used may have contributed to rates of not known data
with regard to demographic information and details of
self-harm. Likewise, given that patients may be reluctant
to report substance use honestly [36] it is likely that the
prevalence of AUS is lower than would have been found
had we used more objective measures of substance use
(e.g. testing blood alcohol concentration upon admission
to the hospital). Furthermore, the use of more objective
self-report measures for substance use could have allowed
for the exploration of important aspects of substance use
and self-harm that have been highlighted in the literature
but were not part of the routine assessment that patients
received. In this study, it would have been helpful to col-
lect data that make a distinction between types of sub-
stance use, determined whether substance use was at a
risky level, established when the individuals were exposed
to the substance in proximity to self-harm, and assessed
the pattern of substance use. Objective measures that
would be appropriate to use in this context include but
are not limited to the Alcohol, Smoking and Substance
Involvement Screening Test (ASSIST), Alcohol Use
Disorder Identification Test (AUDIT), and the Drug Use
Disorder Identification Test (DUDIT). With regard to
self-harm, the Columbia-Suicide Severity Rating Scale or
the Mini International Neuropsychiatric Interview 6
(Module B) could provide insight into the past or present
suicidal ideation, and details of past suicidal behaviour.
Future research should also assess substance use patterns
of behaviour and previous AUS without an act of self-
harm. This study did not control for the influence of con-
founders such as: substance use disorder and comorbid
psychiatric disorders and the context in which the sub-
stances were consumed. Future studies may shed light on
the extent to which a history of substance use among this
sub-group of patients may have played a role in causing
the relationship and financial problems that precipitated
their self-harm. The findings are an important first step in
drawing attention to the prevalence and correlates of
acute substance use among self-harm patients in SA.
Conclusion
Substance use is a potentially modifiable risk factor for sui-
cidal behaviour, yet knowledge on the epidemiology of sub-
stance use among self-harm patients in SA is scant. This
study provides epidemiological data about the prevalence,
correlates, and patterns of medical service utilisation
among self-harm patients who reported substance use at
the time of their self-harm. Given that AUS among self-
harm patients is a public health problem in SA, future re-
search should seek to investigate the context in which AUS
plays a role in self-harm. This would be important espe-
cially in the context of the need to reduce the utilisation of
scarce medical resources in the country and address the
public health problems associated with substance use.
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